Stock SCNI SCINAI IMMUNOTHERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Scinai Immunotherapeutics Ltd.

Equities

SCNI

US09073Q2049

Market Closed - Nasdaq
Other stock markets
 21:30:01 29/04/2024 BST 		5-day change 1st Jan Change
0.4435 USD -3.13% Intraday chart for Scinai Immunotherapeutics Ltd. -3.38% -25.51%
04-08 Exchange-Traded Funds, Equity Futures Gain Slightly Pre-Bell Monday as June Rate Cut Likelihood Falls MT
04-08 Ayana Pharma Selects Scinai Immunotherapeutics' CDMO Unit to Provide Drug Development and cGMP Manufacturing Services CI

Chart calendar Scinai Immunotherapeutics Ltd.

16c59d1fd7b633a61c714af5e8a.upylDODHG7STltsI4uiJmMVt3ek5V7okAUgP6SQt5QM.6s_QbtGPKMzHoOJDiYSx7vUvhbNIBYxPRgoiq2EZgFSIsfJB0_ZogOf8ig~ba1086dac2644b8018e4c2c7d34e9669

Upcoming events on Scinai Immunotherapeutics Ltd.

29/05/2024 Q1 2024 Earnings Release (Projected)
21/08/2024 Q2 2024 Earnings Release (Projected)
25/11/2024 Q3 2024 Earnings Release (Projected)

Past events on Scinai Immunotherapeutics Ltd.

Today Q4 2023 Earnings Release (Projected)
17/04/2024 13:45 Dermatology Drug Development Summit
17/04/2024 10:00 Dermatology Drug Development Summit
17/03/2024 BioEurope Spring Conference
04/03/2024 MIXiii International Life Science and Health-tech Conference
09/01/2024 15:00 Business Update Call
05/11/2023 23:00 BIO-Europe Conference
31/10/2023 12:23 Q3 2023 Earnings Release
23/10/2023 23:00 CPHI Barcelona Conference
12/09/2023 LSX World Congress
10/09/2023 H.C. Wainwright Global Investment Conference
24/08/2023 14:00 Annual General Meeting
11/08/2023 14:00 Q2 2023 Earnings Release
15/05/2023 21:45 Q1 2023 Earnings Release
17/04/2023 21:25 Q4 2022 Earnings Release
21/03/2023 10:30 BIO-Europe Spring Conference
06/02/2023 21:15 BIO CEO and Investor Conference
22/01/2023 Transdermal and Microneedle Drug Delivery Conference
09/01/2023 17:30 Biotech Showcase
08/01/2023 JP Morgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-21,3
-15,2
-40.25%		-22,7
-19,1
-18.74%		0,00


-10,8
-12,3
11.81%		-11,1
-13,4
17.46%
-10,4

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-24,3
-13,2
-83.83%		-31,6
-19,1
-65.49%		0,00


-12,4
-15,9
21.83%		-5,80
-19,2
69.81%
0,00

Net income
Million USD		Released
Forecast
Spread 		-24,3
-13,2
-83.83%		-31,6
-19,1
-65.49%		-1,36


-12,4
-14,2
12.29%		-5,80
-15,7
63.13%
-7,08

EPS
USD		Released
Forecast
Spread 		-0,94
-0,50
-88.72%		-0,95
-0,60
-57.93%		-1,22


-8,68
-4,20
-106.68%		-4,00
-5,62
28.83%
-1,78

Announcement Date30/04/1912/06/2013/05/2128/03/2217/04/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD		Released
Forecast
Spread


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread


-3,40
-4,84
29.68%		-2,49
-3,36
25.73%		-3,30
-3,30
-0.02%		1,12
-3,60
131.21%		-6,77
-3,13
-116.64%		-3,19
-2,60
-22.54%		-2,60
-2,80
7.32%		-2,10
-2,70
22.15%
-2,50

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-3,34
-6,90
51.55%		-2,83
-3,40
16.72%		-3,93
-3,70
-6.34%		1,09
-4,00
127.21%		-0,57
-4,20
86.48%


-3,76
-2,70
-39.33%		3,11
-3,00
203.57%


Net income
Million USD		Released
Forecast
Spread 		-2,86


-3,34
-4,97
32.76%		-2,83
-3,52
19.64%		-3,93
-3,70
-6.34%		1,09
-4,00
127.21%		-0,57
-4,03
85.89%		-3,52
-2,61
-34.67%		-3,76
-2,85
-32%		3,11
-3,09
200.55%
-2,91

EPS
USD		Released
Forecast
Spread 		-2,53


-2,48
-0,85
-191.79%		-2,39
-1,00
-139.26%		-0,06
-0,10
38.8%		0,03
-0,10
129.1%		0,00
-1,08
- 		-1,20
-0,73
-64.38%		-1,20
-0,91
-31.87%		0,80
-0,94
185.11%
-0,62

Announcement Date30/11/2128/03/2201/06/2225/08/2230/11/2217/04/2315/05/2311/08/2331/10/23-

Upcoming sector events for Scinai Immunotherapeutics Ltd.

30/04/2024 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 AZENTA, INC.: Q2 2024 Earnings Release (Projected)
01/05/2024 11:30 UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release
01/05/2024 11:30 BIO-TECHNE CORPORATION: Q3 2024 Earnings Release
01/05/2024 12:00 ALKERMES PLC: Q1 2024 Earnings Release
01/05/2024 VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release
01/05/2024 CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Scinai Immunotherapeutics Ltd.

Today CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
29/04/2024 21:05 QIAGEN N.V.: Q1 2024 Earnings Release
28/04/2024 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
28/04/2024 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
28/04/2024 MORPHOSYS AG: Q1 2024 Earnings Release
26/04/2024 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
26/04/2024 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00 BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024 BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SCNI Stock
  4. Calendar Scinai Immunotherapeutics Ltd.